Avrobio is working to make conditioning, a necessary step for some gene therapies, safer. But it’s not stopping at improving current approaches—the company is teaming up with Magenta Therapeutics to see if an antibody-drug conjugate can do the job.

The FDA has delayed its decision on whether to approve Bristol Myers Squibb’s CAR-T cell therapy by three months. Bristol Myers attributed the delay to its submission of additional information upon the request of the FDA.

The highest level of microplastics ever recorded on the seafloor has been identified by scientists at the Mediterranean, near Italy with the contamination being pulled from the sediments at the bottom.

Based on existing tissue clearing technology, an optimized three-dimensional (3D) tissue-staining and observation technique based has been established by a RIKEN research team. The study, published in the journal Nature Communications, details how the new technique can be used to stain tissue and label cells in whole marmoset bodies, human brains, and mouse brains. Detailed anatomical analysis and whole-organ comparisons between species at the cellular level can be achieved through this technique.

Months into the spread of the coronavirus in the United States, widespread diagnostic testing still isn’t available, and California offers a sobering view of the dysfunction blocking the way.

Venture capital firm Frazier Healthcare Partners has grabbed Scott Byrd, Ian Mills, M.D., and Gordon McMurray, Ph.D., as its new entrepreneur-in-residence consultants.

In the United States, hepatocellular or liver cancer deaths have doubled since 1979. Hepatitis C virus is the leading cause of liver cancer. Around 1998, lifesaving drugs to treat hepatitis C – prohibitively expensive for some – were approved and launched. Historically, other lifesaving drugs such as active antiretroviral drug therapy for human immunodeficiency virus (HIV) and surfactant for respiratory distress syndrome (RDS) of the newborn have led to increasing racial inequalities in mortality following their introduction in the U.S.

The Largest Arctic Ozone Hole Closed Now

When the axons that extend from neurons break during a spinal cord injury, the result is often a lifelong loss of motor functioning, because vital connections from the brain to other body parts cannot be restored. Now, researchers from Temple University’s Lewis Katz School of Medicine say they may have found a way to recover some functions lost to axon breaks.

A new, artificial intelligence-powered diagnostic was able to detect the early signs of glaucoma on the cellular level in a clinical trial, a full year-and-a-half before current testing methods.